Kikuchi-Fujimoto disease

Authors

Keywords:

LYMPHADENITIS, HISTIOCYTIC NECROTIZING LYMPHADENITIS, LYMPHADENOPATHY.

Abstract

Introduction: Kikuchi-Fujimoto disease is a rare cause of cervical lymphadenopathy. It is characterized by a focal proliferation of reticular cells accompanied by numerous histiocytes and extensive nuclear remains.

Objective: to present a patient with Kikuchi-Fujimoto disease diagnosed by the Department of Pathology.

Case report: a 33-year-old, male, black race, HIV patient came to the clinic for presenting a prolonged febrile syndrome and lymphadenopathy in the neck region. With the administration of local anesthesia and sedation, adenopathies excision was performed and a histiocytic-necrotizing lymphadenitis or Kikuchi-Fujimoto disease was diagnosed.

Conclusions: Kikuchi-Fujimoto disease is a rare entity with an uncertain etiology. The accurate diagnosis is obtained from the pathologic-histological study of a biopsy and the treatment included the use of antipyretics and non-steroidal anti-inflammatory drugs.

Downloads

Download data is not yet available.

Author Biographies

Yudelky Almeida Esquivel, Hospital Universitario Manuel Ascunce Domenech. Camaguey. Cuba.

Especialista de Primer Grado en Anatomía Patológica. Instructor.

Karell Piñón García, Hospital Universitario Manuel Ascunce Domenech. Camaguey. Cuba.

Especialista de Primer Grado en Anestesiología y Reanimación. Profesor Asistente. Diplomado Medicina Intensiva y Emergencias.

Johenis Creagh García, Hospital Universitario Manuel Ascunce Domenech. Camaguey. Cuba.

Especialista de Primer Grado en Anatomía Patológica. Profesor Asistente.

References

1. Bolaños-Aguilar MA, Celis-Vera KD, Barragán-Garfias JA, Orrantia-Vértiz M, Duarte-Mote J. Enfermedad de Kikuchi-Fujimoto, manifestación junto con siliconosis. Rev Med Int Méx [Internet]. 2018 [citado 11/04/2020]; 34(2): 335-41. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_abstract&pid=S0186-48662018000200016&lng=es&nrm=iso

2. Castro Corredor D, De Lara Simón IM, Bellido Pastrana D. Enfermedad de Kikuchi-Fujimoto: evolución en brotes con respuesta a antipalúdicos. Rev Esp Patol [Internet]. 2018 [citado 11/04/2020]; 51(1): 34-6. Disponible en: https://www.elsevier.es/es-revista-revista-espanola-patologia-297-articulo-enfermedad-kikuchi-fujimoto-evolucion-brotes-con-S1699885516300587

3. López-Villegas VJ, Medina-Morales DA, Alzate-Piedrahita JA, Moreno Aguirre A, Saldarriaga Rivera LM. Enfermedad de Kikuchi-Fujimoto en una paciente con lupus eritematoso sistémico y linfadenopatía generalizada. Reporte de caso. Rev colom reumatol [Internet]. 2018 [citado 11/04/2020]; 25(3): 216-20. Disponible en: https://www.elsevier.es/es-revista-revista-colombiana-reumatologia-374-articulo-enfermedad-kikuchi-fujimoto-una-paciente-con-S0121812317301032

4. Salamat S, Chan J, Jolly K, Powell G, Harrison K, Ahanger S, et al. Kikuchi–Fujimoto Disease and Prognostic Implications. Head Neck Pathol [Internet]. 2020 [citado 11/04/2020]; 14(1): 272-5. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021859/

5. Nizamuddin, Ubaid A, Waheed F. Arthritis as a Presenting Feature of Kikuchi-Fujimoto Disease: Time to Think Out of the Box in Patients with Arthritis. Rev Hamdan Med J [Internet]. 2020 [citado 11/04/2020]; 13: 55-6. Disponible en: https://www.semanticscholar.org/paper/Arthritis-as-a-presenting-feature-of-disease%3A-Time-Nizamuddin-Ubaid/a9fe3c7e2bb9180c7cb747f43b88be5c5a6867ce

6. Shabana M, Warnack W. An atypical neurologic complication of Kikuchi-Fujimoto disease. Rev Neurology: Neuroimmunology & Neuroinflammation [Internet]. 2020 [citado 11/04/2020]; 7(3): [aprox. 3 p.]. Disponible en: https://nn.neurology.org/content/7/3/e707

7. Perry AM, Choi SM. Kikuchi-Fujimoto Disease a review. Rev Arch Pathol Lab Med [Internet]. 2018 [citado 11/04/2020]; 142(11): 1341-46. Disponible en: https://www.archivesofpathology.org/doi/full/10.5858/arpa.2018-0219-RA

8. Sharma K, Otieno F, Shah R. Case Report of Kikuchi-Fujimoto Disease from Sub-Saharan Africa: An Important Mimic of Tuberculous Lymphadenitis. Case Reports in Medicine [Internet]. 2020 [citado 11/04/2020]; (2020). Disponible en: https://www.hindawi.com/journals/crim/2020/4385286/

9. Raposo André D, Vincente F, Chaves J, Caldeira M, Jacinto F, Chaves AJ, et al. Kikuchi-Fujimoto syndrome: a rare entity to consider. European Journal of Case Reports in Internal Medicine [Internet]. 2020 [citado 11/04/2020]; (7). Disponible en: https://www.ejcrim.com/index.php/EJCRIM/article/view/1456/2077

10.Kara PO, Koç ZP, Çıtak EC, Karaman F, Yaldız M. Kikuchi fujimoto disease mimicking lymphoma detected on pet-ct imaging in a pediatric patient. Rev Int J Radiol Radiat Ther [Internet]. 2018 [citado 11/04/2020]; 5(4): 217-8. Disponible en: https://medcraveonline.com/IJRRT/kikuchi-fujimoto-disease-mimicking-lymphoma-detected-on-pet-ct-imaging-in-a-pediatric-patient.html

11. Sarfraz S, Rafique H, Ali H and Hassan SZ. Case Report: Kikuchi-Fujimoto Disease: A case of supraclavicular lymphadenopathy [version 1; peer review: 1 approved, 1 approved with reservations]. Rev F1000Research [Internet]. 2019 [citado 11/04/2020]; 8(1652): [aprox. 8 p.]. Disponible en: https://f1000research.com/articles/8-1652

12. Córdova-Pluma VH, Vega-López CA, Alarcón-Sotelo A, Riancho-Guzmán JA, Almeida-Navarro JS, Salinas-Lezama E. Enfermedad de Kikuchi-Fujimoto. Rev Med Int Méx [Internet]. 2017 [citado 11/04/2020]; 33(4): 540-7. Disponible en: https://medicinainterna.org.mx/article/enfermedad-de-kikuchi-fujimoto-2/

Downloads

Published

2021-01-22

How to Cite

1.
Almeida Esquivel Y, Piñón García K, Creagh García J. Kikuchi-Fujimoto disease. Rev Ciencias Médicas [Internet]. 2021 Jan. 22 [cited 2025 Aug. 28];25(1):e4563. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/4563

Issue

Vol. 25 No. 1 (2021)

Section

CASE REPORTS

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/